Leukocytes in diabetic retinopathy

Current Diabetes Reviews

Volumn 3, Issue 1, 2007, Pages 3-14

  Chibber, Rakesh ^a   Ben Mahmud, Bahaedin M ^a   Chibber, Surina ^a   Kohner, Eva M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Diabetes; Leukocytes; Retinopathy

Indexed keywords

ACETYLSALICYLIC ACID; ARGATROBAN; BENFOTIAMINE; CORTICOSTEROID; EPALRESTAT; ETANERCEPT; FLUINDOSTATIN; GLICLAZIDE; GROWTH FACTOR; MELOXICAM; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PRAVASTATIN; PROTEIN KINASE C BETA INHIBITOR; RUBOXISTAURIN;

ARTICLE; BLINDNESS; BLOOD RETINA BARRIER; BLOOD VESSEL OCCLUSION; BLOOD VESSEL PERMEABILITY; CAPILLARY BASEMENT MEMBRANE; CAPILLARY ENDOTHELIUM; CELL ADHESION; CELL DAMAGE; CELL DEATH; CELL LOSS; CLINICAL TRIAL; DEVELOPED COUNTRY; DIABETES MELLITUS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE COURSE; DRUG MEGADOSE; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE FUNCTION; LEUKOSTASIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERICYTE; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA CAPILLARY; RETINA FLUORESCEIN ANGIOGRAPHY; VASCULAR ENDOTHELIUM; VISUAL IMPAIRMENT;

ANIMALS; DIABETES COMPLICATIONS; DIABETIC RETINOPATHY; DISEASE PROGRESSION; ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES; MODELS, BIOLOGICAL;

EID: 34247098288     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339907779802139     Document Type: Article

References (136)

1. Kahn HA, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol 1974; 78: 58-67.
2. Klein R, Klein BEK, Moss SE, Cruickshanks K. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, XVII: the 14-year incidence and progression of diabetic retinopathy and associated risk factors in type I diabetes. Ophthalmology 1998; 105: 1801-5.
3. Danne T, Kordonouri O, Enders I, Hovener G, Weber B. Factors modifying the effect of hyperglycemia on the development of retinopathy in adolescents with diabetes. Results of the Berlin Retinopathy Study. Horm Res 1998; 50: 28-32
4. Wilkinson CP, Ferris FL 3rd, Klein RE, et al. Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110: 1677-82.
5. Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care 2004; 27: 2540-53.
6. Watkins PJ. Retinopathy. BMJ 2003; 326: 924-26.
7. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care 1998; 21: 143-56.
8. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
9. UKPDS Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-53.
10. Chung SS, Chung SK. Aldose reductase in diabetic microvascular complications. Curr Drug Targets 2005; 6: 475-86.
11. Setter SM, Campbell RK, Cahoon CJ. Biochemical pathways for microvascular complications of diabetes mellitus. Ann Pharmacother 2003; 37: 1858-66.
12. Frank RN. Diabetic retinopathy. N Engl J Med 2004; 350: 48-58.
13. The PKC-DRS Study Group. The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) multicenter randomized clinical trial. Diabetes 2005; 54: 2188-97.
14. Hammes HP, Du X, Edelstein D, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 2003; 9: 294-99.
15. Krady JK, Basu A, Allen CM, et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 2005; 54: 1559-65.
16. Wilkinson-Berka JL. Angiotensin and diabetic retinopathy. Int J Biochem Cell Biol 2005; 38: 752-65.
17. Kohner EM, Chibber R. In: Tooke JE Ed, Diabetic Angiopathy. Oxford, Oxford University Press 1999; 233-41.
18. Kimble JA, Brandt BM, McGwin G Jr. Clinical examination accurately locates capillary nonperfusion in diabetic retinopathy. Am J Ophthalmol 2005; 139: 555-57.
19. Kohner EM, Patel V, Rassam SM. Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 1995; 44: 603-7.
20. Kurose I, Anderson DC, Miyasaka M, et al. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res 1994; 74: 336-43.
21. Sagel J, Colwell JA, Crook L, Laimins M. Increased platelet aggregation in early diabetus mellitus. Ann Intern Med 1975; 82: 733-38.
22. Schmid-Schonbein H. Microrheology of erythrocytes, blood viscosity, and the distribution of blood flow in the microcirculation. Int Rev Physiol 1976; 9: 1-62.
23. Kelly LW, Barden CA, Tiedeman JS, Hatchell DL. Alterations in viscosity and filterability of whole blood and blood cell subpopulations in diabetic cats. Exp Eye Res 1993; 56: 341-47.
24. Hofman P, van Blijswijk BC, Gaillard PJ, Vrensen GF, Schlingemann RO. Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion. Arch Ophthalmol 2001 119; 861-6.
25. Schroder S, Palinski W, Schmid-Schonbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy.Am J Pathol 1991; 139: 81-100.
26. Miyamoto K, Hiroshiba N, Tsujikawa A, Ogura Y. In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. Invest Ophthalmol Vis Sci 1998; 39: 2190-94.
27. Miyamoto K, Ogura Y, Kenmochi S, Honda Y. Role of leukocytes in diabetic microcirculatory disturbances. Microvasc Res 1997; 54: 43-8.
28. Miyamoto K, Khosrof S, Bursell SE, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci U. S. A. 1999; 96: 10836-41.
29. Barouch FC, Miyamoto K, Allport JR, et al. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci 2000; 41: 1153-58.
30. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. Leukocyte-mediated endothelial cell injury and death in the diabetic Retina. Am J Pathol 2001; 158: 147-52.
31. Lutty GA, Ogura Y: Involvement of leukocytes in diabetic retinopathy and choroidopathy. In: Schmid-Schonbein GW, Granger DN Eds, Molecular Basis for Microcirculatory Disorders. Paris, Springer-Verlag, 2003; 559-69.
32. Adamis AP. Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol 2002; 86: 363-65
33. van Hecke MV, Dekker JM, Nijpels G, et al. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoom Study. Diabetologia 2005; 48:1300-6.
34. Meleth AD, Agron E, Chan CC, et al. Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 2005; 46: 4295-301.
35. Lutty GA, Cao J, Mcleod DS. Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. Am J Pathol 1997; 151: 707-14.
36. Kim SY, Johnson MA, McLeod DS, Alexander T, Hansen BC, Lutty GA. Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas. Diabetes 2005; 54: 1534-42.
37. MacKinnon JR, Knott RM, Forrester JV. Altered L-selectin expression in lymphocytes and increased adhesion to endothelium in patients with diabetic retinopathy. Br J Ophthalmol 2004; 88: 1137-41.
38. Xu Q, Qaum T, Adamis AP. Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci 2001; 42: 789-94.
39. Musashi K, Kiryu J, Miyamoto K, et al. Thrombin inhibitor reduces leukocyte-endothelial cell interactions and vascular leakage after scatter laser photocoagulation. Invest Ophthalmol Vis Sci 2005; 46: 2561-66.
40. Tamura H, Miyamoto K, Kiryu J, et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci 2005; 46: 1440-44.
41. Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 2001; 50: 1636-42.
42. Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004; 18: 1450-52.
43. Gonzalez-Amaro R, Sanchez-Madrid F. Cell adhesion molecules: selectins and integrins. Crit Rev Immunol. 1999; 19: 389-429.
44. Harrison AA, Stocker CJ, Chapman PT, et al. Expression of vascular cell adhesion molecule-1 by vascular endothelial cells in immune and nonimmune inflammatory reactions in the skin. J Immunol 1997; 159: 4546-54.
45. Szekanecz Z, Koch AE. Endothelial cells in inflammation and angiogenesis. Curr Drug Targets Inflamm Allergy 2005; 4: 319-23.
46. Simon SI, Green CE. Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu Rev Biomed Eng 2005; 7: 151-85.
47. Alon R, Feigelson S. From rolling to arrest an blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts. Semin Immunol 2002; 14: 93-104.
48. Morigi M, Angioletti S, Imberti B, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-κB-dependent fashion. J Clin Invest 1998; 101: 1905-15.
49. Baumgartner-Parzer SM, Wagner L, Pettermann M, Gessl A, Waldhausl W. Modulation by high glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia 1995; 38: 1367-70.
50. Takami S, Yamashita S, Kihara S, Kameda-Takemura K, Matsuzawa Y. High concentration of glucose induces the expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells. Atherosclerosis 1998; 138: 35-41.
51. Kado S, Wakatsuki T, Yamamoto M, Nagata N. Expression of intercellular adhesion molecule-1 induced by high glucose concentrations in human aortic endothelial cells. Life Sci 2001; 68: 727-37.
52. Altannavch TS, Roubalova K, Kucera P, Andel M. Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation. Physiol Res 2004; 53: 77-82.
53. Hirata F, Yoshida M, Niwa Y, et al. Insulin enhances leukocyte-endothelial cell adhesion in the retinal microcirculation through surface expression of intercellular adhesion molecule-1, Microvasc Res 2005; 69: 135-41.
54. Okouchi M, Okayama N, Imai S, et al. High insulin enhances neutrophil transendothelial migration through increasing surface expression of platelet endothelial cell adhesion molecule-1 via activation of mitogen activated protein kinase. Diabetologia 2002; 45: 1449-56.
55. Zhaboedov GD, Skripnik RL, Sidorova MV. [Contents of T-lymphocytes and expression of intercellular adhesion molecule ICAM-1 in the retina and choroid in diabetic retinopathy] Vestn Oftalmol 2001; 117: 41-3.
56. Piconi L, Quagliaro L, Da Ros R, et al. Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost 2004; 2. 1453-59.
57. Ceriello A. Acute hyperglycaemia and oxidative stress generation. Diabet Med 1997; 14: S45-9.
58. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular diseme in type II diabetes: the epidemiological evidence. Diabetologia 2001; 44: 2107-14.
59. Booth G, Stalker TJ, Lefer AM, Scalia R. Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo. Diabetes 2002; 51: 1556-64.
60. Omi H, Okayama N, Shimizu M, et al. Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells: effect of antidiabetic medicines. J. Diabetes Complications 2002; 16: 201-8.
61. Kouroedov A, Eto M, Joch H, Volpe M, Luscher TF, Cosentino F. Selective inhibition of protein kinase Cbeta2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 2004; 110: 91-6.
62. Okayama N, Omi H, Okouchi M, et al. Mechanisms of inhibitory activity of the aldose reductase inhibitor, epalrestat, on high glucose-mediated endothelial injury: neutrophil-endothelial cell adhesion and surface expression of endothelial adhesion molecules. J Diabetes Complicat 2002; 16:321-6.
63. Omi H, Okayama N, Shimizu M, et al. Statins inhibit high glucose-mediated neutrophil-endothelial cell adhesion through decreasing surface expression of endothelial adhesion molecules by stimulating production of endothelial nitric oxide. Microvasc Res 2003; 65: 118-24.
64. Itoh M, Omi H, Okouchi M, et al. The mechanisms of inhibitory actions of gliclazide on noutrophils-endothelial cells adhesion and surface expression of endothelial adhesion molecules mediated by a high glucose concentration. J Diabetes Complicat 2003; 17:22-6.
65. Kumar S, Singh BK, Kalra N, et al. Novel thiocoumarins as inhibitors of TNF-alpha induced ICAM-1 expression on human umbilical vein endothelial cells (HUVECs) and microsomal lipid peroxidation. Bioorg Med Chem 2005; 13: 1605-13.
66. Sasakawa T, Sasakawa Y, Masunaga T, et al. FK506 suppresses E-selectin, ICAM-1 and VCAM-1 expression on vascular endothelial cells by inhibiting tumor necrosis factor alpha secretion from peripheral blood mononuclear cells. Cytokine 2005; 29: 67-71.
67. Kang JS, Park SK, Yang KH, Kim HM. Silymarin inhibits TNF-alpha-induced expression of adhesion molecules in human umbilical vein endothelial cells. FEBS Lett 2003; 550: 89-93.
68. Ley K. Molecular mechanisms of leakocyte recruitment in the inflammatory process. Cardiovasc Res 1996; 32: 733-42.
69. Meager A. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev 1999; 10: 27-39.
70. Smith CW. Endothelial adhesion molecules and their role in inflammation. Can J Physiol Pharmacol 1993; 71: 76-87.
71. Joussen AM, Poulaki V, Mitsiades N, et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J 2002; 16: 438-40.
72. Doganay S, Evereklioglu C, Er H, et al. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 2002; 16: 163-70.
73. Armstrong D, Augustin AJ, Spengler R, et al. Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ophthalmologica 1998; 212: 410-14.
74. Kumaramanickavel G, Sripriya S, Vellanki RN, et al. Tumor necrosis factor allelic polymorphism with diabetic retinopathy in India. Diabetes Res Clin Pract 2001; 54: 89-94.
75. Limb GA, Chignell AH, Green W, LeRoy F, Dumonde DC. Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 1996; 80: 168-73.
76. Slepova OS, Gerasimenko VL, Zakharova GIu, Novikova-Bilak TI. Comparative study of the role of cytokines in various eye diseases. 2. Diabetic retinopathy. Vestn Oftalmol 2001; 117: 35-7.
77. Hussain MJ, Peakman M, Gallati H, et al. Elevated plasma levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia, 1996; 39: 60-9.
78. Lechleitner M, Koch T, Herold M, Dzien A, Hoppichler F: Tumour necrosis factor-alpha plasms, level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J Intern. Med 2000; 248: 67-76.
79. Foss MC, Foss NT, Paccola GM, Silva CL. Serum levels of tumor necrosis factor in insulin-dependent diabetic patients. Braz J Med Biol Res 1992; 25: 239-42.
80. Bertin E, Nguyen P, Guenounou M, Durlach V, Potron G, Leutenegger M: Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metab 2000; 26: 178-82.
81. McLeod DS, Lefer DJ, Merges C, Lutty GA. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 1995; 147:642-53.
82. Adamis AP. Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol 2002; 86: 363-65.
83. Hughes JM, Brink A, Witmer AN, Hanraads-de Riemer M, Klaassen I, Schlingemann RO. Vascular leucocyte adhesion molecules unaltered in the human retina in diabetes. Br J Ophthalmol 2004; 88: 566-72.
84. Matsumoto K, Sera, Y, Abe Y, Ueki Y, Miyake S. Serum concentrations of soluble vascular cell adhesion molecule-1 and E-selectin are elevated in insulin-resistant patients with type 2 diabetes. Diabetes Care 2001; 24: 1697-98.
85. Cominacini L, Fratta Pasini A, Garbin U, et al. E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress. Diabetologia 1997; 40: 584-89.
86. Ceriello A, Falleti E, Motz E, et al. Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm Metab Res 1998; 30: 146-49.
87. Pecsvarady Z, Fisher TC, Darwin CH, et al. Decreased polymorphonuclear leukocyte deformability in NIDDM. Diabetes Care 1994; 17: 57-63.
88. Linderkamp O, Ruef P, Zilow EP, Hoffmann GF. Impaired deformability of erythrocytes and neutrophils in children with newly diagnosed insulin-dependent diabetes mellitus. Diabetologia 1999; 42: 865-69.
89. Hiramatsu K, Arimori S. Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes 1988; 37: 832-37.
90. Tong PC, Lee KF, So WY, et al. White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes. Diabetes Care 2004; 27: 216-22.
91. Shah SV, Wallin JD, Eilen SD. Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. J Clin Endocrinol Metab 1983; 57: 402-9.
92. Centero M, Parra T, Conejo JR. Increased hydrogen peroxide formation in polymorphonuclear leukocytes of IDDM patients. Diabetes Care 1998; 21: 326-27.
93. Devaraj S, Jialal I. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation. Circulation 2000; 102: 191-6.
94. Freedman S, Hatchell D: Enhanced superoxide radical production by stimulated polymorphonuclear leukocytes in a cat model of diabetes. Exp Eye Res 1992; 55: 767-73.
95. Karima M, Kantarci A, Ohira T, et al. Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. J Leukoc Biol 2005; 78: 862-70.
96. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501.
97. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vase Biol 2000; 20: 2175-83.
98. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regal Integr Comp Physiol 2003; 285: R277-97.
99. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000; 85: 2970-73.
100. Ha H, Lee HB. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology (Carlton). 2005; 10:Suppl: S7-S10.
101. Ceolotto G, Gallo A, Miola M, et al. Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes 1999; 48: 1316-22.
102. Venugopal SK, Devaraj S, Yang T, Jialal I. alpha-Tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Diabetes 2002; 51: 3049-54.
103. Kowluru R, Tang J, Kern TS, Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effects of longterm administration of antioxidants on the development of retinopathy. Diabetes 2001; 50: 1938-42.
104. Scott JA, King GL. Oxidative sum and antioxidant treatment in diabetes. Ann N Y Acad Sci 2004; 1031: 204-13.
105. Dosquet C, Weill D, Wautier JL. Molecular mechanism of blood monocyte adhesion to vascular endothelial cells. Nouv Rev Fr Hematol 1992; 34 Suppl: S55-9.
106. Fukuda M. Roles of mucin-type O-glycans in cell adhesion. Biochim Biophys Acts 2002; 1573: 394-405.
107. Lowe JB. Glycosylation in the control of selectin counter-receptor structure and function. Immunol Rev 2002; 186: 19-36.
108. Vestweber D, and Blanks JE. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 1999; 79: 181-13.
109. Patel KD, Cuvelier SL, Wiehler S. Selectins: critical mediators of leukocyte recruitment. Semin Immunol 2002; 14: 73-81.
110. Zak I, Lewandowska E, Gnyp W. Selectin glycoprotein ligands. Acta Biochim Pol 2000; 47: 393-412.
111. Yen TY, Macher BA, Bryson S, et al. Highly conserved cysteines of mouse core 2 beta1, 6-N-acetylglucosaminyltransferase I form a network of disulfide bonds and include a thiol that affects enzyme activity. J Biol Chem 2003; 278: 45864-81.
112. Schachter H, Brockhausen I. In: Allen HJ, Kisailus EC Ed, Glycoconjugates: Composition, Structure, and Function. New York, Marcel Dekker Inc. 1992; 263-332.
113. Williams, D., and Schachter, H. Mucin synthesis. I. Detection in canine submaxillary glands of an N- acetylglucosaminyltransferase which acts on mucin substrates J Biol Chem 1980; 255:11247-52.
114. Laferte S, Dennis JW: Glycosylation-dependent collagen-binding activities of two membrane glycoproteins in MDAY-D2 tumour cells. Cancer Res 1988; 48: 4743-48.
115. Tsuboi S, Fukuda M. Overexpression of branched o-linked oligosaccharides on T cell surface glycoproteins impairs humoral immune responses in transgenic mice. Biol Chem 1998; 273: 30680-87.
116. Yousefi S, Higgins E, Daoling Z, Pollex-Kruger A, Hindsgaul O, Dennis JW: Increased UDP-GlcNAc: Gal (beta] 1-3GalNAcR(GlcNAc to GalNAc) [beta]-1,6-N-acetylglucosaminyltransferase activity in metastic murine tumour cell lines: control of polylactosamine synthesis. J Biol Chem 1991; 266: 1772-82.
117. Higgins EA, Siminovitch KA, Zhuang D, Brockhausen I, Dennis JW: Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. J Biol Chem 1991; 266: 6280-90.
118. Piller F, Piller V, Fox RI, Fukuda M: Human T-lymphocyte activation is associated with changes in O-glycans biosynthesis. J Biol Chem 1989; 263: 15146 50.
119. Koya D, Dennis JW, Warren CE, et al. Overexpression of core 2 N-acetylglycosaminyltransferase enhances cytokine actions and induces hyperetropic myocardium in transgenic mice. FASEB J 1999; 13: 2329-37.
120. Nishio Y, Warren CE, Buczek-Thomas JA, et al. Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue. J Clin Invest 1995; 96: 1759-67.
121. Nguyen M, Strubel NA, Blschoff J. A Role of sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 1993; 365: 267-69.
122. Brockhausen I, Kuhns W, Schachter H, Matta KL, Sutherland DR, Baker MA. Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Galbeta3GalNAcalpha-R(GlcNAc to GalNAc)beta (1,6)-N-acetylglucosaminyltransferase in leukemic cells. Cancer Res 1991; 51: 1257-63.
123. Chibber R, Ben-Mahmud BM, Coppini D, Christ E, Kohner EM. Activity of the glycosylating enzyme core 2 GlcNAc-(beta 1,6) transferase, is higher in polymorphonuclear leukocytes from diabetic patients compared to age-matched control subjects: Relevance to capillary occlusion in diabetic retinopathy. Diabetes 2000; 49: 1724-30.
124. Chibber R, Ben-Mahmud BM, Mann GE, Zhang JJ, Kohner EM. Protein kinase C beta2-dependent phosphorylation of core 2 GlcNAc-T promotes leukocyte-endothelial cell adhesion: a mechanism underlying capillary occlusion in diabetic retinopathy. Diabetes 2003; 52: 1519-27.
125. Ben-Mahmud BM, Mann GE, Datti A, Orlacchio A, Kohner EM, Chibber R. Tumor necrosis factor-alpha in diabetic plasma increases the activity of core 2 GlcNAc-T and adherence of human leukocytes to retinal endothelial cells: significance of core 2 GlcNAc-T in diabetic retinopathy. Diabetes 2004; 53:2968-76.
126. Nonaka A, Kiryu J, Tsujikawa A, et al. PKC-ß Inhibitor (LY333531) attenuates leukocyte entrapment in retinal micro-circulation of diabetic rats. Invest Ophthalmol Vis Sci 2000; 41: 2702-6.
127. Park JY, Takahara N, Gabriele A, et al. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes 2000; 49: 1239-48.
128. Kumar R, Camphausen RT, Sullivan FX, Cumming DA. Core 2 [beta]-1,6-N-acetylglucosaminyltransferase enzyme activity is critical for P-selectin glycoprotein ligand-1 binding to P-selectin. Blood 1996; 88: 3872-79.
129. Constantin G. PSGL-1 as a novel therapeutic target. Drug News Perspect 2004; 17: 579-86.
130. Smith MJ, Smith BR, Lawrence MB, Snapp KR. Functional analysis of the combined role of the O-linked branching enzyme core 2 betal-6-N-glucosaminyltransferase and dimerization of P-selectin glycoprotein ligand-1 in rolling on P-selectin. J Biol Chem 2004; 279: 21984-91.
131. Moore KL, Eaton SF, Lyons DE, Lichenstein HS, Cummings RD, MeEver RP. The P-selectin glycoprotein ligand from human neutrophils displays sialylated, fucosylated, O-linked poly-N-acetyllactosamine. J Biol Chem 1994; 269: 23318-27.
132. Sako D, Chang XJ, Barone KM, et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 1993; 75: 1179-86.
133. Kaplar M, Kappelmayer J, Veszpremi A, Szabo K, Udvardy M. The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy. Platelets 2001; 12: 419-22.
134. Ishibashi T, Tanaka K, Taniguchi Y. Platelet aggregation and coagulation in the pathogenesis of diabetic retinopathy in rats. Diabetes 1981; 30: 601-6.
135. Boeri D, Maiello M, Lorenzi M. Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes 2001; 50: 1432-9.
136. Yamashiro K, Tsujikawa A, Ishida, S, et al. Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdown. Am J Pathol 2003; 163: 253-9.